The Japan tissue diagnostics market is predicted to reach US$ 234 Million by 2030, from around US$ 150 Million in 2024. Japan is one of the leading markets for tissue diagnostics in the Asia-Pacific region. The rising incidence of chronic conditions such as cancer, diabetes, and cardiovascular diseases is driving the need for more advanced tissue diagnostic technologies in the region. Moreover, the population of Japan is aging rapidly with around 30% of the Japanese population aged 65 and over, a demographic that is more vulnerable to chronic conditions. Japan’s quickly aging population leads to an explosion of chronic conditions such as heart disease and cancer. All of these conditions can be diagnosed and monitored using IVD products. Additionally, physicians in Japan are rapidly shifting from traditional testing processes to tissue-based diagnostic techniques, as these tests shorten turnaround times when compared to traditional approaches, thereby propelling the market growth.
Recent Developments
- In January 2024, bioMerieux announced the acquisition of LUMED, a software company that has developed a clinical decision support system to help hospitals optimize antimicrobial prescriptions and monitor healthcare-associated infections.
- In October 2023, Sysmex and Fujirebio entered into a business collaboration agreement in the field of immunoassay, in a bid to promote cooperation to accelerate their global expansion, and to contribute to the development and advancement of immunoassay.
- In August 2023, Sysmex Corporation announced an expansion of the Global Business Partnership Agreement (GBPA) with Roche Diagnostics International Ltd.
- In April 2023, bioMérieux submitted a 510(k) premarket notification to the U.S. FDA for the VITEK REVEAL, formerly known as SPECIFIC REVEAL Rapid AST System. The rapid AST system VITEK REVEAL is already available on-market under CE-IVDD (assay panel) and IVDR (instrument) designation across Europe.
By Segment: Japan IVD Tissue Diagnostics Market - Key Takeaways
- Immunohistochemistry is the largest segment of the tissue diagnostics market. The increasing prevalence of cancer is likely to push the growth of immunohistochemistry (IHC) market over the forecast period. The recent advancements in the field of pathology that are making IHC more crucial, especially for tissue-based diagnoses, are further propelling the market growth.
- Pre-analytical processing is the second largest segment of the tissue diagnostics market. With the advancements in automation technology, more diagnostic laboratories and healthcare settings are likely to adopt automated pre-analytical systems to improve efficiency and reduce errors, thereby driving the market growth.
- Sakura Finetek Japan is the major player in the pre-analytical processing market. Their products are widely used in histopathology, cytology, and other diagnostic processes.
- Hematoxylin and Eosin (H&E) staining is one of the most common and essential staining techniques used in the preparation of tissue samples for microscopic examination, particularly in histology, pathology, and oncology. Muto Pure Chemicals is a prominent player in the Japanese H&E manual staining reagents market.
- ISH is a powerful molecular biology technique used to visualize and locate specific nucleic acid sequences within cells or tissues. The continuous technological advancement in the field of in-vitro diagnostics is a significant driving factors for the in-situ hybridization market. For instance, automation of ISH workflows and the availability of digital imaging systems have made the technique more efficient, reducing hands-on time and improving data analysis.
- Abbott dominates the Japan ISH staining market, as their extensive portfolio enables the company to cater to various diagnostic needs in molecular pathology and oncology.
- Digital pathology is one of the fastest growing segments of the Japan tissue diagnostics market. The adoption of this technology streamlines the process of tissue sample analysis by digitizing pathology slides, allowing for remote collaboration among pathologists and enabling faster and more accurate diagnoses.
- Workflow solutions captured least share of the Japan tissue diagnostics market.
- The report provides a comprehensive assessment of the fast-evolving, high-growth Japan Tissue Diagnostics Market.
This 87 Pages report with 44 Figures has been analyzed from 6 viewpoints:
1) Japan IVD Tissue Diagnostics Market and Forecast (2021 - 2030)
2) Japan IVD Tissue Diagnostics Market Share and Forecast (2021 - 2030)
3) By Segment - Japan IVD Tissue Diagnostics Market & Forecast (2021 - 2030)
4) Japan IVD Tissue Diagnostics Market & Forecast - Company Profiles
5) Japan IVD Market - Recent Developments
6) Japan IVD Tissue Diagnostics Market - Market Dynamics
By Segment: Japan IVD Tissue Diagnostics Market and Forecast
1. Pre-Analytical Processing
2. H&E Staining
3. Special Staining
4. IHC Staining
5. ISH Staining
6. Digital Pathology
7. Workflow Solutions
Japan IVD Tissue Diagnostics Market - Company Analysis
1. Roche
2. Abbott Laboratories
3. Sakura Finetek Japan Co., Ltd.
4. Leica Biosystems
5. Agilent Dako
6. Nichirei Biosciences Inc.
7. Epredia
Data Sources
The publisher employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and in-house analysis by a dedicated team of qualified professionals with deep industry experience and expertise.
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interviews, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.
Table of Contents
Companies Mentioned
- Abbott Laboratories
- Agilent Dako
- Epredia
- Leica Biosystems
- Nichirei Biosciences Inc.
- Roche
- Sakura Finetek Japan Co., Ltd.